| 3762- | H2, | Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment |
| - | in-vivo, | AD, | NA |
| 3763- | H2, | Long-Term Inhalation of Hydrogen Gas for Patients with Advanced Alzheimer's Disease: A Case Report Showing Improvement in Fecal Incontinence |
| - | Case Report, | AD, | NA |
| 3764- | H2, | Therapeutic Effects of Hydrogen Gas Inhalation on Trimethyltin-Induced Neurotoxicity and Cognitive Impairment in the C57BL/6 Mice Model |
| - | in-vivo, | AD, | NA |
| 3765- | H2, | Therapeutic Inhalation of Hydrogen Gas for Alzheimer’s Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot Study |
| - | Study, | AD, | NA |
| 3766- | H2, | The role of hydrogen in Alzheimer′s disease |
| - | Review, | AD, | NA |
| 3767- | H2, | The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges |
| - | Review, | AD, | NA |
| 4343- | H2, | Inhibitory effects of hydrogen on in vitro platelet activation and in vivo prevention of thrombosis formation |
| - | vitro+vivo, | NA, | NA |
| 4344- | H2, | Hydrogen May Inhibit Collagen-Induced Platelet Aggregation: An ex vivo and in vivo Study |
| - | in-vivo, | NA, | NA | - | ex-vivo, | NA, | NA |
| 4347- | H2, | Hydrogen may inhibit collagen-induced platelet aggregation: an ex vivo and in vivo study |
| - | ex-vivo, | NA, | NA |
| 4346- | H2, | Medical Application of Hydrogen in Hematological Diseases |
| - | Review, | NA, | NA |
| 4345- | H2, | The Benefit of Hydrogen Gas as an Adjunctive Therapy for Chronic Obstructive Pulmonary Disease |
| - | Human, | NA, | NA |
| 4237- | H2, | Hydrogen-Rich Saline Protects Against Spinal Cord Injury in Rats |
| - | in-vitro, | NA, | NA |
| 4236- | H2, | Neuroprotective effects of hydrogen inhalation in an experimental rat intracerebral hemorrhage model |
| - | in-vivo, | Stroke, | NA |
| - | in-vivo, | Sepsis, | NA |
| 4234- | H2, | Hydrogen gas alleviates sepsis-induced neuroinflammation and cognitive impairment through regulation of DNMT1 and DNMT3a-mediated BDNF promoter IV methylation in mice |
| - | in-vivo, | Sepsis, | NA |
| 4306- | H2, | Molecular Hydrogen as an Emerging Candidate for Preventing Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4307- | H2, | Hydrogen Gas Attenuates Toxic Metabolites and Oxidative Stress-Mediated Signaling to Inhibit Neurodegeneration and Enhance Memory in Alzheimer’s Disease Models |
| - | in-vivo, | AD, | NA |
| 4308- | H2, | A biomimetic upconversion nanoreactors for near-infrared driven H2 release to inhibit tauopathy in Alzheimer's disease therapy |
| - | in-vivo, | AD, | NA |
| 3769- | H2S, | Research progress of hydrogen sulfide in Alzheimer's disease from laboratory to hospital: a narrative review |
| - | Review, | AD, | NA |
| 286- | HCA, | ALA, | Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report |
| 292- | HCA, | Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway |
| - | in-vitro, | AML, | K562 |
| 293- | HCA, | Tam, | Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase |
| - | in-vitro, | BC, | MCF-7 |
| 294- | HCA, | In Vitro and In Vivo Toxicity of Garcinia or Hydroxycitric Acid: A Review |
| 1415- | HCA, | Hydroxycitrate delays early mortality in mice and promotes muscle regeneration while inducing a rich hepatic energetic status |
| - | in-vivo, | Nor, | NA |
| 1414- | HCA, | Bioefficacy of a novel calcium-potassium salt of (-)-hydroxycitric acid |
| - | Human, | Nor, | NA |
| 1413- | HCA, | Effects of acute (-)-hydroxycitrate supplementation on substrate metabolism at rest and during exercise in humans |
| - | Human, | Nor, | NA |
| 1412- | HCA, | Identification of ATP Citrate Lyase as a Positive Regulator of Glycolytic Function in Glioblastomas |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | LN229 |
| 1637- | HCA, | OLST, | Orlistat and Hydroxycitrate Ameliorate Colon Cancer in Rats: The Impact of Inflammatory Mediators |
| - | in-vivo, | Colon, | NA |
| 1635- | HCA, | Hydroxycitric acid prevents hyperoxaluric-induced nephrolithiasis and oxidative stress via activation of the Nrf2/Keap1 signaling pathway |
| - | vitro+vivo, | Nor, | NA |
| 1589- | HCA, | ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism |
| - | Review, | NA, | NA |
| 1625- | HCA, | In S. cerevisiae hydroxycitric acid antagonizes chronological aging and apoptosis regardless of citrate lyase |
| - | Review, | Nor, | NA |
| 1627- | HCA, | CRMs, | Sper, | Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance |
| - | Review, | Var, | NA |
| 1628- | HCA, | ALA, | Addition of Hydroxy Citrate improves effect of ALA |
| - | Review, | Var, | NA |
| 1629- | HCA, | Tam, | Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase |
| - | in-vitro, | BC, | MCF-7 |
| 1630- | HCA, | Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia |
| - | Review, | NA, | NA |
| 1634- | HCA, | Hydroxycitrate: a potential new therapy for calcium urolithiasis |
| - | Human, | Nor, | NA |
| 1633- | HCA, | Hydroxycitric Acid Alleviated Lung Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress and Ferroptosis through the Hif-1α Pathway |
| - | in-vivo, | NA, | NA | - | in-vitro, | Nor, | HUVECs |
| 1631- | HCA, | An overview of the safety and efficacy of a novel, natural(-)-hydroxycitric acid extract (HCA-SX) for weight management |
| - | Review, | Obesity, | NA |
| 1645- | HCAs, | Chapter 8 - Hydroxycinnamic Acids: Natural Sources, Biosynthesis, Possible Biological Activities, and Roles in Islamic Medicine |
| - | Review, | Nor, | NA |
| 1657- | HCAs, | Anticancer Activity of Sinapic Acid by Inducing Apoptosis in HT-29 Human Colon Cancer Cell Line 2023 |
| - | in-vitro, | CRC, | HT-29 |
| 1638- | HCAs, | Anticancer potential of hydroxycinnamic acids: mechanisms, bioavailability, and therapeutic applications |
| - | Review, | Nor, | NA |
| 1641- | HCAs, | Lung cancer induced by Benzo(A)Pyrene: ChemoProtective effect of sinapic acid in swiss albino mice |
| - | in-vitro, | Lung, | A549 | - | in-vivo, | Lung, | NA |
| 1643- | HCAs, | Mechanisms involved in the anticancer effects of sinapic acid |
| - | Review, | Var, | NA |
| 1644- | HCAs, | PBG, | Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis |
| - | in-vitro, | Pca, | LNCaP |
| 1649- | HCAs, | Anticancer Properties of Hydroxycinnamic Acids -A Review |
| - | Review, | Var, | NA |
| 2400- | HCAs, | The Mixture of Ferulic Acid and P-Coumaric Acid Suppresses Colorectal Cancer through lncRNA 495810/PKM2 Mediated Aerobic Glycolysis |
| - | in-vitro, | CRC, | NA | - | in-vivo, | CRC, | NA |
| 2407- | HCAs, | 2'-hydroxycinnamaldehyde inhibits cancer cell proliferation and tumor growth by targeting the pyruvate kinase M2 |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | LNCaP |
| 602- | HCAs, | Prooxidant activity of hydroxycinnamic acids on DNA damage in the presence of Cu(II) ions: mechanism and structure-activity relationship |
| - | Analysis, | NA, | NA |
| 1441- | HCQ, | Chemo, | Case report: stage 4 pancreatic cancer to remission using paricalcitol and hydroxychloroquine in addition to traditional chemotherapy |
| - | Case Report, | GBM, | NA |
| 1439- | HCQ, | Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine |
| - | in-vitro, | Melanoma, | NA | - | in-vitro, | CRC, | HCT116 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid